The Tapering Dose of Luspatercept in Patients With Lower-risk Myelodysplastic Syndromes
Clinical trial NCT05925504 · RECRUITING
Trial details
- NCT number
- NCT05925504
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-01
- Primary completion
- 2026-06-30
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.